Ceftazidime is used to treat lower respiratory tract, skin, urinary tract, blood-stream, joint, and abdominal infections, and meningitis. Ceftazidime, sold under the brand name Fortaz among others, is a third-generation cephalosporin antibiotic useful for the treatment of a number of bacterial infections
A Anant Labs fabrica e fornece impurezas de Ceftazidime de alta qualidade para o mercado global. Nossas impurezas EP de Ceftazidime são utilizadas por fabricantes de APIs e empresas farmacêuticas totalmente integradas em todo o mundo.
Sinônimos
ceftazidime72558-82-8ceftazidimaFortazCeftazidime anhydrousceftazidimumTazidimePentacefTazicefFortumCeptazGR 20263FortamCHEBI:3508Tazidime In Plastic Container(6R,7R)-7-[[(2Z)-2-(2-amino-1,3-thiazol-4-yl)-2-(2-carboxypropan-2-yloxyimino)acetyl]amino]-8-oxo-3-(pyridin-1-ium-1-ylmethyl)-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylateNSC-759260DZR1ENT301SN 401 pentahydrateGR-20263LY-139381DTXSID5022770J01DD07LY 139381LY1393819M416Z9QNR1-{[(6R,7R)-7-[(2Z)-2-(2-amino-1,3-thiazol-4-yl)-2-[(1-carboxy-1-methylethoxy)imino]acetamido]-2-carboxylato-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-en-3-yl]methyl}pyridin-1-iumAVYCAZ COMPONENT CEFTAZIDIMEZAVICEFTA COMPONENT CEFTAZIDIMEGR20263Kefazim(6R,7R)-7-(((2Z)-2-(2-amino-1,3-thiazol-4-yl)-2-(2-carboxypropan-2-yloxyimino)acetyl)amino)-8-oxo-3-(pyridin-1-ium-1-ylmethyl)-5-thia-1-azabicyclo(4.2.0)oct-2-ene-2-carboxylate1-(((6R,7R)-7-((2Z)-2-(2-amino-1,3-thiazol-4-yl)-2-((1-carboxy-1-methylethoxy)imino)acetamido)-2-carboxylato-8-oxo-5-thia-1-azabicyclo(4.2.0)oct-2-en-3-yl)methyl)pyridin-1-iumPyridinium, 1-((7-(((2-amino-4-thiazolyl)((1-carboxy-1-methylethoxy)imino)acetyl)amino)-2-carboxy-8-oxo-5-thia-1-azabicyclo(4.2.0)oct-2-en-3-yl)methyl)-, hydroxide, inner salt, pentahydrate, (6R-(6alpha,7beta(Z)))-RefChem:574981ceftazidime (for pentahydrate)DTXCID702770J01DA11CEFTAZIDIME IN DEXTROSE CONTAINER(6R,7R)-7-(((2Z)-2-(2-amino-1,3-thiazol-4-yl)-2-(2-carboxylatopropan-2-yloxyimino)acetyl)amino)-8-oxo-3-(pyridin-1-ium-1-ylmethyl)-5-thia-1-azabicyclo(4.2.0)oct-2-ene-2-carboxylate;hydron2-((Z)-(1-(2-amino-1,3-thiazol-4-yl)-2-(((6R,7R)-2-carboxy-8-oxo-3-(pyridin-1-ium-1-ylmethyl)-5-thia-1-azabicyclo(4.2.0)oct-2-en-7-yl)amino)-2-oxoethylidene)amino)oxy-2-methylpropanoate276-715-9Ceftazidime [INN]Ceftazidime (contains ca. 10% Na2CO3)Ceftazidime (INN)Fortaz (TN)(6R,7R)-7-[[2-(2-Amino-1,3-thiazol-4-yl)-2-(2-carboxypropan-2-yloxyimino)acetyl]amino]-8-oxo-3-(pyridin-1-ium-1-ylmethyl)-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylateCAZMFCD00072034Ceftazimide(6R,7R)-7-((Z)-2-(2-Aminothiazol-4-yl)-2-(((2-carboxypropan-2-yl)oxy)imino)acetamido)-8-oxo-3-(pyridin-1-ium-1-ylmethyl)-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate (contains ca. 10% Na2CO3)Ceptaz (TN)Ceftazidime (Standard)CEFTAZIDIME [MI]Epitope ID:118711Ceftazidime/Sodium CarbonateSCHEMBL36849CEFTAZIDIME [WHO-DD]BIDD:GT0734CHEMBL44354Ceftazidime - Bio-X trade markGTPL10762HY-B0593RGLXC-23148HMS2090M13HY-B0593MSK10012BDBM50420259EBC-27302AKOS015951273CCG-269983DB00438NCGC00179584-05BC300021CEFTAZIDIME (ARGININE FORMULATION)FA153265AB00513848NS00009344C06889D07654G60912AB00513848-02EN300-22411480Q808845Ceftazidime (containing approximately 10% sodium carbonate)(6R,7R)-7-((Z)-2-(2-Aminothiazol-4-yl)-2-(((2-carboxypropan-2-yl)oxy)imino)acetamido)-8-oxo-3-(pyridin-1-ium-1-ylmethyl)-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate(containsca.10%Na2CO3)(6R,7R)-7-({(2Z)-2-(2-amino-1,3-thiazol-4-yl)-2-[(1-carboxy-1-methylethoxy)imino]acetyl}amino)-8-oxo-3-(pyridinium-1-ylmethyl)-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate(6R,7R)-7-{[(2Z)-2-(2-amino-1,3-thiazol-4-yl)-2-{[(2-carboxypropan-2-yl)oxy]imino}acetyl]amino}-8-oxo-3-(pyridinium-1-ylmethyl)-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate(6R,7R)-7-{[(2Z)-2-(2-Amino-1,3-thiazol-4-yl)-2-{[(2-carboxypropan-2-yl)oxy]imino}acetyl]amino}-8-oxo-3-[(pyridin-1-ium-1-yl)methyl]-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate1-(((6R,7R)-7-(((2Z)-(2-AMINO-4-THIAZOLYL)((1-CARBOXY-1-METHYLETHOXY)IMINO)ACETYL)AMINO)-2-CARBOXY-8-OXO-5-THIA-1-AZABICYCLO(4.2.0)OCT-2-EN-3-YL)METHYL)PYRIDINIUM INNER SALT1-(((6R,7R)-7-(2-(2-AMINO-4-THIAZOLYL)GLYOXYLAMIDO)-2-CARBOXY-8-OXO-5-THIA-1-AZABICYCLO(4.2.0)OCT-2-EN-3-YL)METHYL)PYRIDINIUM HYDROXIDE INNER SALT 7(SUP 2)-(Z)-(O-(1-CARBOXY-1-METHYLETHYL)OXIME)7beta-{[(2Z)-2-(2-amino-1,3-thiazol-4-yl)-2-{[(2-carboxypropan-2-yl)oxy]imino}acetyl]amino}-3-(pyridinium-1-ylmethyl)-3,4-didehydrocepham-4-carboxylatePYRIDINIUM, 1-(((6R,7R)-7-(((2Z)-(2-AMINO-4-THIAZOLYL)((1-CARBOXY-1-METHYLETHOXY)IMINO)ACETYL)AMINO)-2-CARBOXY-8-OXO-5-THIA-1-AZABICYCLO(4.2.0)OCT-2-EN-3-YL)METHYL)-, INNER SALTPYRIDINIUM, 1-((7-(((2-AMINO-4-THIAZOLYL)((1-CARBOXY-1-METHYLETHOXY)IMINO)ACETYL)AMINO)-2-CARBOXY-8-OXO-5-THIA-1-AZABICYCLO(4.2.0)OCT-2-EN-3-YL)METHYL)-, HYDROXIDE, INNER SALT, (6R-(6.ALPHA.,7.BETA.(Z)))-Pyridinium, 1-[[(6R,7R)-7-[[(2Z)-2-(2-amino-4-thiazolyl)-2-[(1-carboxy-1-methylethoxy)imino]-1-oxoethyl]amino]-2-carboxy-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-en-3-yl]methyl]-, inner salt